Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age

NCT04642079 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
839
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer